Emeritus Professor Robert Tindle
Emeritus Professor

Robert Tindle

Email: 

Availability

Emeritus Professor Robert Tindle is:
Available for supervision
Media expert

Qualifications

  • Bachelor (Honours) of Science (Advanced), Institution to be confirmed
  • Doctor of Philosophy, University College London

Research impacts

The CD34 stem cell has replaced marrow transplation in the treatment of leukaemias and other diseases throughout the world.

The tolerogenic effect of the HPV 16 E7 oncoprotein informs the design of therapeutic vaccines for human cervical cancer.

Search Professor Robert Tindle’s works on UQ eSpace

105 works between 1975 and 2024
All (105) Journal Article (86) Book Chapter (5) Conference Publication (9) Book (2) Other Outputs (3)

1 - 20 of 105 works

2024

Journal Article

Long COVID: Sufferers can take heart

Tindle, Robert (2024). Long COVID: Sufferers can take heart. Australian Journal of General Practice, 4 (4), 238-240. doi: 10.31128/AJGP-07-23-6896

Long COVID: Sufferers can take heart

2024

Journal Article

Long COVID: Sufferers can take heart

Tindle, Robert (2024). Long COVID: Sufferers can take heart. Australian Journal of General Practice, 53 (4), 238-240. doi: 10.31128/AJGP-07-23-6896

Long COVID: Sufferers can take heart

2023

Journal Article

Tumour-agnostic immunotherapy for rare and uncommon cancers

Tindle, Robert (2023). Tumour-agnostic immunotherapy for rare and uncommon cancers. Australian Journal of General Practice, 52 (12), 889-892. doi: 10.31128/AJGP-03-23-6772

Tumour-agnostic immunotherapy for rare and uncommon cancers

2022

Book

Your Cash … or Your Cancer

Tindle, Robert (2022). Your Cash … or Your Cancer. Brisbane, QLD Australia: Ocean Reeve Publishing.

Your Cash … or Your Cancer

2016

Other Outputs

A Curious Life: One man’s path to discovery and the breakthrough that saved thousands of lives

Tindle, Robert (2016). A Curious Life: One man’s path to discovery and the breakthrough that saved thousands of lives. Brisbane, Queensland: Boolarong Press.

A Curious Life: One man’s path to discovery and the breakthrough that saved thousands of lives

2014

Journal Article

The biology of an isolated population of the American Flamingo Phoenicopterus ruber in the Galapagos Islands

Tindle, Robert W., Tupiza, Arnaldo, Blomberg, Simon P. and Tindle, L. Elizabeth (2014). The biology of an isolated population of the American Flamingo Phoenicopterus ruber in the Galapagos Islands. Galapagos Research, 68.

The biology of an isolated population of the American Flamingo Phoenicopterus ruber in the Galapagos Islands

2014

Journal Article

Genetic and phenotypic evidence supports evolutionary divergence of the American flamingo (Phoenicopterus ruber) population in the Galápagos Islands

Frias-Soler, Roberto, Tindle, Elizabeth, Lopez, Georgina Espinosa, Blomberg, Simon, Studer-Thiersch, Adelheid, Wink, Michael and Tindle, Robert (2014). Genetic and phenotypic evidence supports evolutionary divergence of the American flamingo (Phoenicopterus ruber) population in the Galápagos Islands. Waterbirds, 37 (4), 349-361. doi: 10.1675/063.037.0402

Genetic and phenotypic evidence supports evolutionary divergence of the American flamingo (Phoenicopterus ruber) population in the Galápagos Islands

2013

Journal Article

Population dynamics of the Galapagos Flightless Cormorant Phalacrocorax harrisi in relation to sea temperature

Tindle, Robert W., Tindle, Elizabeth, Vagenas, Dimitrios and Harris, Michael P. (2013). Population dynamics of the Galapagos Flightless Cormorant Phalacrocorax harrisi in relation to sea temperature. Marine Ornithology, 41 (2), 121-133.

Population dynamics of the Galapagos Flightless Cormorant Phalacrocorax harrisi in relation to sea temperature

2010

Journal Article

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection

Haigh, O., Kattenbelt, J., Cochrane, M., Thomson, S., Gould, A. and Tindle, R. (2010). Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. Cancer Gene Therapy, 17 (10), 708-720. doi: 10.1038/cgt.2010.27

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection

2010

Journal Article

HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens

Chen, Dekun, Edgtton, Kristy, Gould, Allan, Guo, Huayang, Mather, Michael, Haigh, Oscar, Cochrane, Melanie, Kattenbelt, Jacqueline, Thomson, Scott and Tindle, Robert (2010). HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens. Virology, 398 (1), 68-78. doi: 10.1016/j.virol.2009.11.042

HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens

2010

Journal Article

Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.

Herd, K. A., Nelson, M., Mahalingam, S. and Tindle, R. W. (2010). Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.. Journal of General Virology, 91 (5), 1302-1310. doi: 10.1099/vir.0.015396-0

Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.

2009

Other Outputs

HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease

Chen, Dekun, Gould, Allan, Mather, Michael, Haigh, Oscar, Barnes, Melanie, Kattenbelt, Jacqueline, Thomson, Scott and Tindle, Robert (2009). HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease.

HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease

2009

Journal Article

Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses

Gu, Wenyi, Cochrane, Melanie, Leggatt, Graham, Payne, Elizabeth, Choyce, Allison, Zhou, Fang, Tindle, Robert and McMillan, Nigel (2009). Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proceedings of the National Academy of Sciences of the United States of America, 106 (20), 8314-8319. doi: 10.1073/pnas.0812085106

Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses

2008

Journal Article

Genetically modified hepatitis B surface antigen: A Powerful vaccine technology for the delivery of disease-associated foreign antigens.

Thomson, S., Haigh, O., Gould, A. R. and Tindle, R. W. (2008). Genetically modified hepatitis B surface antigen: A Powerful vaccine technology for the delivery of disease-associated foreign antigens.. Current Drug Therapy, 3 (3), 226-234. doi: 10.2174/157488508785747844

Genetically modified hepatitis B surface antigen: A Powerful vaccine technology for the delivery of disease-associated foreign antigens.

2008

Journal Article

Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease

Herd, K. A., Nissen, M. D., Hopkins, P. M., Sloots, T. P. and Tindle, R. W. (2008). Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. The Journal of Infectious Diseases, 197 (4), 584-592. doi: 10.1086/526536

Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease

2008

Journal Article

Recombinant Hepatitis B surface antigen vaccines for the delivery of disease-related antigens.

Tindle, Robert W., Oscar Haigh, Gould, Allan R. and Scott Thomson (2008). Recombinant Hepatitis B surface antigen vaccines for the delivery of disease-related antigens.. Current Trends in Immunology, 9, 51-60.

Recombinant Hepatitis B surface antigen vaccines for the delivery of disease-related antigens.

2007

Journal Article

Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protection

Haigh, Oscar, Guo, Huayang, Edgtton, Kristy, Mather, Michael, Herd, Karen A. and Tindle, Robert W. (2007). Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protection. Virology, 368 (2), 363-375. doi: 10.1016/j.virol.2007.06.041

Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protection

2007

Journal Article

Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine

Herd, Karen A., Wiethe, Carsten and Tindle, Robert W. (2007). Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine. Vaccine, 25 (28), 5209-5219. doi: 10.1016/j.vaccine.2007.04.083

Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine

2006

Journal Article

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes

Woo, Wai-Ping, Doan, Tracy, Herd, Karen A., Netter, Hans-Jurgen and Tindle, Robert W. (2006). Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. Journal Of Virology, 80 (8), 3975-3984. doi: 10.1128/JVI.80.8.3975-3984.2006

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes

2006

Journal Article

Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice

Herd, Karen A., Mahalingam, Suresh, Mackay, Ian M., Nissen, Michael, Sloots, Theo P. and Tindle, Robert W. (2006). Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. Journal of Virology, 80 (4), 2034-2044. doi: 10.1128/JVI.80.4.2034-2044.2006

Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice

Past funding

  • 2008
    SASVRC Study and Travel & Infrastucture
    Royal Children's Hospital Foundation
    Open grant
  • 2006 - 2008
    Development of Hepatitis B surface antigen as a generic vector for the delivery of foreign CTL epitopes.
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Mechanisms of disease caused by human metapneumovirus and protection using a novel polytype vaccine
    University of Canberra
    Open grant
  • 2005 - 2006
    Co-administration of DNA encoding co-stimulatory molecules enhances the efficacy of immune response to foreign antigen
    NHMRC Project Grant
    Open grant
  • 2004 - 2006
    Development of a vaccine for human metapneumovirus-associated respiratory disease in children
    Royal Children's Hospital Foundation
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant _HLTH_CICR_Med SCD
    NHMRC Equipment Grant
    Open grant
  • 2004 - 2005
    Novel cancer vaccine delivery using recombinant Hepatitus B surface antigen VLP- and DNA vectors
    Queensland Cancer Fund
    Open grant
  • 2003 - 2004
    Novel polytope VLP vaccines for respiratory syncytial virus (RSV) infection in children
    Royal Children's Hospital Foundation
    Open grant
  • 2002
    Development of a HBV-specific carrier matrix to induce an immune response against quasispecies-like infectious agents
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    A Vaccine to Break Tolerance to Cervical Carcunoma Oncoprotein
    NHMRC Project Grant
    Open grant
  • 1999
    A 'polyepitope' DNA vaccine encoding CTL epitopes of HPV16 E7 restricted by multiple MHC class 1 haplotypes, protects against endogenous E7-expressing epithelial tumour: a cervical cancer DNA vaccine
    Cancer Bequest Fund
    Open grant
  • 1999 - 2000
    A recombinant Kunjin virus replicon vaccine will protect against the growth of a tumour expressing a tumour specific antigen
    Queensland Cancer Fund
    Open grant
  • 1999 - 2001
    Immunological Consequences of Epithelial Expression of a Viral Oncoprotein Associated with Cervical Carcinoma
    NHMRC Project Grant
    Open grant
  • 1998 - 1999
    The Body's Responses to Antigens in Skin in Adult Life
    Royal Children's Hospital Foundation
    Open grant
  • 1997
    Immunological consequences of neo-antigen presentation at the periphery
    UQ External Support Enabling Grant
    Open grant
  • 1996 - 1998
    Human papillomavirus (HPV) 16 E7 and squamous cell cancer: CTL and tumour protection elicited by oral recombinant Salmonella vaccines containing human CTL epitopes
    Queensland Cancer Fund
    Open grant
  • 1996 - 1997
    Immunity to peripheral 'non-self' antigen in mice transgenic for HPV transforming protein
    Queensland Cancer Fund
    Open grant
  • 1996
    Immunological consequences of neo-antigen presentation at the periphery
    NHMRC Project Grant
    Open grant
  • 1996 - 1997
    Human papillomavirus (HPV) 16 E7 and squamous cell cancer: CTL and tumour protection elicited by oral recombinant Salmonella vaccines containing human CTL epitopes
    Queensland Cancer Fund
    Open grant
  • 1995 - 1998
    The immunobiology of HPV-associated cancers
    United States National Institutes of Health
    Open grant

Availability

Emeritus Professor Robert Tindle is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Enquiries

Contact Emeritus Professor Robert Tindle directly for media enquiries about:

  • Human papillomavirus
  • Human respiratory viruses
  • Immune system and disease
  • Immunisation
  • Immunology
  • Papillomavirus
  • Respiratory viruses
  • T-cells
  • Vaccines
  • Viral immunology
  • Virology
  • Viruses

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au